Immune Tolerance Network
Lauren Higdon has a diverse work experience in the field of medical research. Lauren is currently serving as the Director of Biomarker & Discovery Research at Immune Tolerance Network since 2022. Prior to this, they worked at Stanford University School of Medicine as an Instructor from July 2020 to July 2022 and as a Postdoctoral Fellow from September 2015 to July 2020. Lauren also gained experience as a Postdoctoral Researcher at the University of Pennsylvania from September 2014 to September 2015 and as a PHD Graduate Student at the University of Washington from September 2009 to June 2014.
Lauren Higdon completed their Bachelor of Science degree in Biology, with Honors, from Stanford University in 2009. Afterwards, they pursued a Doctor of Philosophy (PhD) in Molecular and Cellular Biology at the University of Washington from 2009 to 2014.
Immune Tolerance Network
The Immune Tolerance Network (ITN) is a collaborative network for clinical research, funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. Our mission is to accelerate the clinical development of immune tolerance therapies in asthma and allergy, autoimmune diseases, type 1 diabetes and solid organ transplantation. Immune tolerance therapies reprogram the immune system so that disease-causing immune responses are stopped while maintaining the immune system’s ability to combat pathogen infection. The ITN develops, funds and conducts clinical trials in conjunction with mechanistic, laboratory based studies.